1[1]Liniger R,Popovic R,Sullivan B,et al.Effects of neuroprotective cocktails on hippocampal neuron death in an in vitro modle of cerebral ischemia [J].J Neurosurgi Anesthesiol,2001,13:19-25.
2[2]Tottene A,Volsen S,Pietrobon D.Subunits form the pore of three cerebellar R-type calcium channels with different pharmacological and permeation properties[J].J Neurosci,2000,20:171-178.
3[3]Horn J,de-Haan RJ,Vermeulen M,et al.Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review[J].Stroke,2001,32: 2433-2438.
4[4]Hossmann KA.The hypoxic brain.Insights from ischmia research[J].Adv Exp Med Biol,1999,474:155-169.
5[5]Lyden PD,Lu M,Levine SR,et al.A modified National Institutes of Health Stroke Scale for use in stroke clinical trials:preliminary reliability and validity[J].Stroke,2001,32:1310-1317.
6[6]Tanaka K.Functions of glutanmate transporters in the brain[J].Neurosci Res,2000,37:15-19.
7[7]Zhang RL,Zhang ZG,Chopp M.Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat[J].Neurology,1999,52:273-279.
8[8]Coppieters MW,Stappaerts KH,Wouters LL,et al.Aberrant protective force generation during neural provocation testing and the effect of treatment in patients with neurogenic cervicobrachial pain[J].J Manipulative Physiol Ther,2003,26:99-106.
9[9]Hutchinson PJ,O'Connell MT,Coles JP,et al.Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a neuroprotective agent[J].Br J Clin Pharmacol,2002,53:275-283.
10[10]Szu H,Noel S,Yim SB,et al.Multimedia authenticity protection with ICA watermarking and digital bacteria vaccination[J].Neural Netw ,2003,16:907-914.
